KS
Kamal Sharma
About Kamal Sharma
Data last updated:
Kamal Sharma is a Director at Vecnost Biotechnology Private Limited (since 2021) and Director at Recxia Formulations Private Limited (since 2007). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹4.49 Cr; the largest is Vecnost Biotechnology Private Limited at ₹3.54 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vecnost Biotechnology Private Limited U24290PB2021PTC053235 | Director | 16 Apr 2021 | 2021 | ₹3.54 Cr (FY 2025) | Active |
| Recxia Formulations Private Limited U24232PB2007PTC031183 | Director | 31 May 2007 | 2007 | ₹95 Lakh (FY 2025) | Active |
Board colleagues of Kamal Sharma
| Name | DIN | Company | Designation |
|---|---|---|---|
| Anil Pawan Gupta | 11144685 | Vecnost Biotechnology Private Limited | Director |
| Sunil Kumar Gupta | 11144683 | Vecnost Biotechnology Private Limited | Director |
| Manish Pahwa | 03637655 | Recxia Formulations Private Limited | Additional Director |
| Meenakshi Pahwa | 08203113 | Recxia Formulations Private Limited | Additional Director |
| Pawan Kapoor | 03638277 | Recxia Formulations Private Limited | Additional Director |
| Satish Chander Puri | 03637636 | Recxia Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kamal Sharma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kamal Sharma
Kamal Sharma currently holds 2 directorships: Vecnost Biotechnology Private Limited (Director, since 16 Apr 2021, revenue ₹3.54 Cr (FY 2025)); Recxia Formulations Private Limited (Director, since 31 May 2007, revenue ₹95 Lakh (FY 2025)).
Kamal Sharma was first appointed on 31 May 2007 as Director at Recxia Formulations Private Limited. The most recent appointment on record is 16 Apr 2021 at Vecnost Biotechnology Private Limited.
The 2 current companies of Kamal Sharma that report revenue have a combined latest revenue of ₹4.49 Cr: Vecnost Biotechnology Private Limited ₹3.54 Cr (FY 2025); Recxia Formulations Private Limited ₹95 Lakh (FY 2025).
The current boards of Kamal Sharma's companies include Anil Pawan Gupta (Vecnost Biotechnology Private Limited), Sunil Kumar Gupta (Vecnost Biotechnology Private Limited), Manish Pahwa (Recxia Formulations Private Limited), Meenakshi Pahwa (Recxia Formulations Private Limited), Pawan Kapoor (Recxia Formulations Private Limited), Satish Chander Puri (Recxia Formulations Private Limited).